Nanexa AB (publ)
STO: NANEXA.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- David Westberg
- Employees
- 13
- Headquarters
- Uppsala, Sweden
- IPO year
- 2015
- Market cap
- SEK 561.7M
- Website
- https://www.nanexa.com
Loading NANEXA…
Loading profile data…Frequently asked questions about NANEXA
What does Nanexa AB (publ) (NANEXA.ST) do?
Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007...
Where does NANEXA.ST trade?
Nanexa AB (publ) (NANEXA.ST) trades on the Stockholm Stock Exchange.
What sector is NANEXA.ST in?
Nanexa AB (publ) (NANEXA.ST) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Nanexa AB (publ)?
David Westberg is the chief executive officer of Nanexa AB (publ) (NANEXA.ST).
Where is Nanexa AB (publ) headquartered?
Nanexa AB (publ) is headquartered in Sweden.
Does NANEXA.ST pay a dividend?
Nanexa AB (publ) (NANEXA.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NANEXA.ST go public?
Nanexa AB (publ) (NANEXA.ST) completed its initial public offering in 2015.